301 related articles for article (PubMed ID: 21470278)
1. Clinical question: What is the best approach to managing glucocorticoid-induced osteoporosis?
Compston J
Clin Endocrinol (Oxf); 2011 May; 74(5):547-50. PubMed ID: 21470278
[TBL] [Abstract][Full Text] [Related]
2. [Glucocorticoid-induced osteoporosis : treatment update].
Soen S
Clin Calcium; 2012 Feb; 22(2):229-35. PubMed ID: 22298077
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
De Nijs RN
Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
[TBL] [Abstract][Full Text] [Related]
4. Skeletal morbidity in inflammatory bowel disease.
van Hogezand RA; Hamdy NA
Scand J Gastroenterol Suppl; 2006; (243):59-64. PubMed ID: 16782623
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid-induced osteoporosis.
Berris KK; Repp AL; Kleerekoper M
Curr Opin Endocrinol Diabetes Obes; 2007 Dec; 14(6):446-50. PubMed ID: 17982350
[TBL] [Abstract][Full Text] [Related]
6. Management of glucocorticoid-induced osteoporosis.
Compston J
Nat Rev Rheumatol; 2010 Feb; 6(2):82-8. PubMed ID: 20125175
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of teriparatide in treatment of glucocorticoid-induced osteoporosis].
Soen S
Clin Calcium; 2012 Mar; 22(3):315-20. PubMed ID: 22370297
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid induced risk of fractures.
Maruotti N; Corrado A; Cantatore FP
Panminerva Med; 2010 Dec; 52(4):339-43. PubMed ID: 21183894
[TBL] [Abstract][Full Text] [Related]
9. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid-induced osteoporosis and its treatment.
Pennisi P; Trombetti A; Rizzoli R
Clin Orthop Relat Res; 2006 Feb; 443():39-47. PubMed ID: 16462424
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of glucocorticoid-induced osteoporosis.
Civitelli R; Ziambaras K
J Endocrinol Invest; 2008 Jul; 31(7 Suppl):2-6. PubMed ID: 18791344
[TBL] [Abstract][Full Text] [Related]
12. [Guidelines for the treatment of glucocorticoid-induced osteoporosis and their future problems].
Soen S
Clin Calcium; 2006 Nov; 16(11):1788-96. PubMed ID: 17079844
[TBL] [Abstract][Full Text] [Related]
13. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.
Siris ES; Baim S; Nattiv A
Postgrad Med; 2010 Jan; 122(1):82-90. PubMed ID: 20107292
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.
Cruse LM; Valeriano J; Vasey FB; Carter JD
J Clin Rheumatol; 2006 Oct; 12(5):221-5. PubMed ID: 17023807
[TBL] [Abstract][Full Text] [Related]
15. Prevention and treatment of glucocorticoid-induced osteoporosis.
Doga M; Mazziotti G; Bonadonna S; Patelli I; Bilezikian JP; Canalis E; Giustina A
J Endocrinol Invest; 2008 Jul; 31(7 Suppl):53-8. PubMed ID: 18791353
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid-induced osteoporosis.
Tamura Y; Okinaga H; Takami H
Biomed Pharmacother; 2004 Nov; 58(9):500-4. PubMed ID: 15511606
[TBL] [Abstract][Full Text] [Related]
17. Preventing osteoporotic fractures in older people.
McCloskey E
Practitioner; 2011 Jan; 255(1736):19-22, 2-3. PubMed ID: 21370710
[TBL] [Abstract][Full Text] [Related]
18. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.
Menopause; 2010; 17(1):25-54; quiz 55-6. PubMed ID: 20061894
[TBL] [Abstract][Full Text] [Related]
19. [Vitamin K2 as a potential therapeutic agent for glucocorticoid-induced osteoporosis].
Tanana I; Oshima H
Clin Calcium; 2006 Nov; 16(11):1851-7. PubMed ID: 17079852
[TBL] [Abstract][Full Text] [Related]
20. [Prophylaxis of glucocorticoid-induced osteoporosis].
Tanaka Y
Clin Calcium; 2006 Nov; 16(11):1858-65. PubMed ID: 17079853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
